AAAAAA

   
Results: 1-17 |
Results: 17
DIAGNOSIS, CLASSIFICATION, AND CYTOGENETICS OF MYELODYSPLASTIC SYNDROMES
Authors: VALLESPI T IMBERT M MECUCCI C PREUDHOMME C FENAUX P
Citation: T. Vallespi et al., DIAGNOSIS, CLASSIFICATION, AND CYTOGENETICS OF MYELODYSPLASTIC SYNDROMES, Haematologica, 83(3), 1998, pp. 258-275
MANTLE CELL LYMPHOMA - PRESENTING FEATURES, RESPONSE TO THERAPY AND PROGNOSTIC FACTORS
Authors: BOSCH F LOPEZGUILLERMO A CAMPO E RIBERA JM CONDE E PIRIS MA VALLESPI T WOESSNER S MONTSERRAT E
Citation: F. Bosch et al., MANTLE CELL LYMPHOMA - PRESENTING FEATURES, RESPONSE TO THERAPY AND PROGNOSTIC FACTORS, Cancer, 82(3), 1998, pp. 567-575
ETIOPATHOLOGY, PROGNOSIS AND THERAPY OF MYELODYSPLASTIC SYNDROMES
Authors: SANZ GF SANZ MA VALLESPI T
Citation: Gf. Sanz et al., ETIOPATHOLOGY, PROGNOSIS AND THERAPY OF MYELODYSPLASTIC SYNDROMES, HEM CELL TH, 39(6), 1997, pp. 277-294
CYTOGENETIC FINDINGS IN 121 PATIENTS WITH REFRACTORY-ANEMIA - PROGNOSTIC VALUE
Authors: SOLE F ESPINET B WOESSNER S PRIETO F GRANADA I CRUZCIGUDOSA J GARCIA L CALASANZ MJ ARRANZ E BENITEZ J RIOS R LUNO E VALLESPI T PALAU L DIEZ JL HERNANDEZ JM BUREO E PEREZ MM MARTIN ML
Citation: F. Sole et al., CYTOGENETIC FINDINGS IN 121 PATIENTS WITH REFRACTORY-ANEMIA - PROGNOSTIC VALUE, Cytogenetics and cell genetics, 77(1-2), 1997, pp. 342-342
APPLICATION OF THE INTERNATIONAL SCORING SYSTEM FOR MYELODYSPLASIA TOM.D.-ANDERSON PATIENTS - RESPONSE
Authors: GREENBERG P LEBEAU MM FENAUX P MOREL P SANZ G SANZ M VALLESPI T HAMBLIN T OSCIER D OHYASHIKI K TOYAMA K AUL C MUFTI G COX C BENNETT J
Citation: P. Greenberg et al., APPLICATION OF THE INTERNATIONAL SCORING SYSTEM FOR MYELODYSPLASIA TOM.D.-ANDERSON PATIENTS - RESPONSE, Blood, 90(7), 1997, pp. 2844-2846
CRITERIA TO TREAT YOUNGER CLL PATIENTS WITH EXPERIMENTAL THERAPIES - A PROPOSAL BASED ON THE STUDY OF 179 PATIENTS UNDER THE AGE OF 50
Authors: MONTSERRAT E BOSCH F JARQUE I VALLESPI T MOREY M RIOS A MENCHACA C RIBERA JM WOESSNER S ROMERO A DIAZMEDIAVILLA J BRUNET S
Citation: E. Montserrat et al., CRITERIA TO TREAT YOUNGER CLL PATIENTS WITH EXPERIMENTAL THERAPIES - A PROPOSAL BASED ON THE STUDY OF 179 PATIENTS UNDER THE AGE OF 50, Blood, 90(10), 1997, pp. 395-395
INTERNATIONAL SCORING SYSTEM FOR EVALUATING PROGNOSIS IN MYELODYSPLASTIC SYNDROMES
Authors: GREENBERG P COX C LEBEAU MM FENAUX P MOREL P SANZ G SANZ M VALLESPI T HAMBLIN T OSCIER D OHYASHIKI K TOYAMA K AUL C MUFTI G BENNETT J
Citation: P. Greenberg et al., INTERNATIONAL SCORING SYSTEM FOR EVALUATING PROGNOSIS IN MYELODYSPLASTIC SYNDROMES, Blood, 89(6), 1997, pp. 2079-2088
INCIDENCE AND CHARACTERISTICS OF LYMPHOID MALIGNANCIES IN UNTREATED MYELODYSPLASTIC SYNDROMES
Authors: FLORENSA L VALLESPI T WOESSNER S DOMINGO A CRESPO N ROZMAN M AGUILAR JL IRRIGUIBLE D ZARCO A MILLA F FELIU E
Citation: L. Florensa et al., INCIDENCE AND CHARACTERISTICS OF LYMPHOID MALIGNANCIES IN UNTREATED MYELODYSPLASTIC SYNDROMES, Leukemia & lymphoma, 23(5-6), 1996, pp. 609-612
MYELODYSPLASTIC SYNDROMES
Authors: SANMIGUEL JF SANZ GF VALLESPI T DELCANIZO MC SANZ MA
Citation: Jf. Sanmiguel et al., MYELODYSPLASTIC SYNDROMES, Critical reviews in oncology/hematology, 23(1), 1996, pp. 57-93
MANTLE CELL LYMPHOMA (MCL) - PRESENTING FAILURES AND PROGNOSTIC FACTORS IN A SERIES OF 59 PATIENTS
Authors: BOSCH F LOPEZGUILLERMO A CAMPO E PIRIS MA CONDE E RIBERA JM VALLESPI T WOESSNER S MONTSERRAT E
Citation: F. Bosch et al., MANTLE CELL LYMPHOMA (MCL) - PRESENTING FAILURES AND PROGNOSTIC FACTORS IN A SERIES OF 59 PATIENTS, Blood, 88(10), 1996, pp. 889-889
INTERNATIONAL WORKSHOP CONSENSUS RISK ANALYSIS SYSTEM FOR MYELODYSPLASTIC SYNDROMES (MDS)
Authors: GREENBERG P FENAUX P MOREL P SANZ G SANZ M VALLESPI T HAMBLIN T OSCIER D OHYASHIKI K TOYAMA K AUL C MUFTI G BENNETT J COX C LEBEAU M
Citation: P. Greenberg et al., INTERNATIONAL WORKSHOP CONSENSUS RISK ANALYSIS SYSTEM FOR MYELODYSPLASTIC SYNDROMES (MDS), Blood, 86(10), 1995, pp. 1065-1065
INCIDENCE AND CHARACTERISTICS OF LYMPHOID MALIGNANCIES IN UNTREATED MYELODYSPLASTIC SYNDROMES
Authors: VALLESPI T FLORENSA L WOESSNER S DOMINGO A CRESPO N ROZMAN M AGUILAR JL IRRIGUIBLE D ZARCO MA MILLA F FELIU E
Citation: T. Vallespi et al., INCIDENCE AND CHARACTERISTICS OF LYMPHOID MALIGNANCIES IN UNTREATED MYELODYSPLASTIC SYNDROMES, Blood, 86(10), 1995, pp. 3199-3199
GRANULAR LYMPHOCYTE PROLIFERATIVE DISORDERS - A MULTICENTER STUDY OF 20 CASES
Authors: WOESSNER S FELIU E VILLAMOR N ZARCO MA DOMINGO A MILLA F FLORENSA L ROZMAN M ABELLA E SOLER J VALLESPI T IRRIGUIBLE MD SOLE F
Citation: S. Woessner et al., GRANULAR LYMPHOCYTE PROLIFERATIVE DISORDERS - A MULTICENTER STUDY OF 20 CASES, Annals of hematology, 68(6), 1994, pp. 285-292
CYTOGENETIC STUDIES IN 5 PATIENTS WITH SEZARY-SYNDROME
Authors: SOLE F WOESSNER S VALLESPI T LOSADA AP FLORENSA L IRRIGUIBLE D VILA J SANSSABRAFEN J
Citation: F. Sole et al., CYTOGENETIC STUDIES IN 5 PATIENTS WITH SEZARY-SYNDROME, Cancer genetics and cytogenetics, 75(2), 1994, pp. 130-132
CYTOGENETIC ABNORMALITIES AND MYELODYSPLASIA FOLLOWING IMMUNOSUPPRESSIVE THERAPY FOR APLASTIC-ANEMIA
Authors: VALLESPI T JHANWAR S CHILDS B CASTROMALASPINA H
Citation: T. Vallespi et al., CYTOGENETIC ABNORMALITIES AND MYELODYSPLASIA FOLLOWING IMMUNOSUPPRESSIVE THERAPY FOR APLASTIC-ANEMIA, Blood, 84(10), 1994, pp. 10000315-10000315
ISOCHROMOSOME-17Q AS A SOLE ANOMALY - A DISTINCT MYELODYSPLASTIC SYNDROME ENTITY
Authors: SOLE F TORRABADELLA M GRANADA I FLORENSA L VALLESPI T RIBERA JM IRRIGUIBLE D MILLA F WOESSNER S
Citation: F. Sole et al., ISOCHROMOSOME-17Q AS A SOLE ANOMALY - A DISTINCT MYELODYSPLASTIC SYNDROME ENTITY, Leukemia research, 17(8), 1993, pp. 717-720
KARYOTYPE ANALYSIS IN 181 PRIMARY MYELODYSPLASTIC SYNDROMES (MDS)
Authors: VALLESPI T SANZ G PUJOL A LOPEZ F JAEN A IRRIGUIBLE D JULIA A SOLE F CANIZO MC SANMIGUEL JF SANZ MA
Citation: T. Vallespi et al., KARYOTYPE ANALYSIS IN 181 PRIMARY MYELODYSPLASTIC SYNDROMES (MDS), Blood, 82(10), 1993, pp. 10000557-10000557
Risultati: 1-17 |